Brief: Adagene Reports Full Year 2021 Financial Results
March 31 (Reuters) - Adagene Inc 978y.F :
* ADAGENE REPORTS FULL YEAR 2021 FINANCIAL RESULTS AND
PROVIDES
CORPORATE UPDATE
* ADAGENE INC - CASH AND CASH EQUIVALENTS WERE US$174.4
MILLION AS
OF DECEMBER 31, 2021, COMPARED TO US$75.2 MILLION AS OF DECEMBER
31, 2020
Source text for Eikon: ID:nGNX26J3SM
Further company coverage: 978y.F
((reuters.briefs@thomsonreuters.com;))
Recent news on Adagene
See all newsBrief: Adagene Inc Announces Offering Of American Depositary Shares
Brief: Adagene Announces FDA Fast Track Designation For Muzastotug (Adg126)
Brief: Adagene Expands SAFEBody Deal With Exelixis To Develop Third Novel Masked Antibody-Drug Conjugate
Brief: Adagene Inc - Partners With Conjugatebio For Antibody Drug Conjugate Development
Brief: Adagene Announces Up To $25 Million Strategic Investment From Sanofi